- About Us
- Pharmalicensing - Open Innovation for the life sciences
- Our Products
- Overview
- Partnering Search
- Company Profiling
- Partneringtools
- Reports
- Partnering Consulting
- Due Diligence
- Comparison
- Due Diligence
- Overview
- Top Applications
- Online Panel Discussions
- Request Consultation
- Case Studies
- See what others think about our service
- Newsletter
- Partnering update
- Key reports
- Subscribe
- Quick Links
- Profile now
- Register now
- Profiled companies
- Featured events
- Industry news
- PR Newswire
- Jobs
- Forums
- Contact Pharmalicensing
- Send an email
- Call us: +44 1904 520460
- Request a callback
- RSS Feeds
- Keep up to date
is a division of
Dilon Technologies Receives CE Mark for Medical Imaging System
- Gamma Camera sales to be launched in Europe
—
NEWPORT NEWS, Virginia, May 6NEWPORT NEWS, Virginia, May 6 /PRNewswire/ -- Dilon Technologies announced today that it has received CE Mark (Conformite Europeenne) approval for the commercial sale of the Dilon 6800 Gamma Camera in European Union member countries. The Dilon system is a high-resolution gamma camera that enables molecular imaging of the breast and other small organs for early cancer detection.
"I am delighted that our high technology camera will now also be available to customers in Europe and other parts of the world that require the CE mark. The body of clinical evidence related to our camera's performance and ability to detect tumors continues to mount; now medical professionals around the world will have access to this advanced diagnostic technology. Given the large international market potential for our camera, I am very excited about our company's future growth prospects," said Robert Moussa, Chairman and CEO.
About Dilon Technologies
Dilon Technologies is bringing innovative new medical products to the market based on research conducted at leading national research laboratories. Dilon's cornerstone product is the Dilon 6800 Gamma Camera -- a high-resolution, anatomic-specific gamma camera, which is now being used to perform Breast-Specific Gamma Imaging (BSGI), a molecular imaging technique that images the metabolic activity of breast lesions through radiotracer uptake. Several leading medical centers around the country are now offering BSGI to their patients, including: Beth Israel Medical Center, New York; George Washington University Medical Center, Washington, D.C.; Alexian Brothers Medical Center, Chicago; Methodist Hospital, Philadelphia; and West Valley Imaging, Las Vegas.
To find out more about BSGI or the Dilon 6800 Gamma Camera please visit http://www.dilon.com
Web site: http://www.dilon.com
Related news
Related News
- ICON Medical Imaging Launches New Service to Boost Reliability of Cardiology Studies
- Medinol Receives CE Mark for Presillion(TM) Cobalt Chromium Coronary Stent on Rx System, an Advanced Evolution of the NIR(R) Family of Stents
- OrbusNeich Receives CE Mark Approval for Sapphire(TM) 1.25MM PTCA Dilatation Catheter
- OrbusNeich Receives CE Mark Approval for Scoreflex(TM) Coronary Dilatation Catheter
- Mortara Receives Frost & Sullivan Award for DICOM ECG
- Therakos, Inc. Receives CE Mark in Europe For Next-Generation Photopheresis System
- MS Society Receives Praise From Prime Minister on Joining Medical Research Awards
- Elekta Receives CE Mark Clearance for 'Everyday Radiation Therapy' Accelerator, Elekta Compact
- ES Vascular Receives CE Mark for its First Aortic Stapler for End-to-End Anastomosis Between Synthetic Grafts and Aorta During Open Repair of Aortic Aneurysmal and Occlusive Disease
- DxTech Receives Development Funding
Latest News
- The Future of Financing Health Services in Africa
- Unique Digital Breast Screening Part of Offering by New Clinic
- Canada Supports Ground-Breaking Malaria Treatment Program in Sub-Saharan Africa
- Unite's NHS Members Hold Day of Action on Wednesday, 3 December Over Pay
- Beat the Credit Crunch This Christmas With High Quality American Peanuts!
- Dynamics Group AG Publishes Research Report on Senetek
- diaDexus Receives CE Mark Certification for the PLAC(R) Test
- Improving Occupational Safety and Health Worldwide
- German Innovation for HIV/AIDS Diagnostics Has Been Used 2.5 Million Times in 2008
- Elsevier's EMBASE.com Partners With QUOSA
© Copyright 1995-2008 Pharmalicensing Ltd, is a division of 
All rights reserved. Terms and Conditions | Site map | Contact us